Domingo, E., Camps, C., Kaisaki, P., Parsons, M., Mouradov, D., Pentony, M., . . . Tomlinson, I. (2018). Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent. Elsevier.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.